Curated Resources — FDA warning Tysabri Progressive Multifocal Leukoencephalopathy

Below is a working bibliography of trusted health, pharmacovigilance, and legal-analysis sources, compiled for open research.

Featured analysis

FDA warning Tysabri Progressive Multifocal Leukoencephalopathy — Background & Analysis — detailed background and analysis.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

PubMed Central (PMC)

Reference: PubMed Central (PMC)

Authoritative source for clinical, regulatory, and public-health background reading.